Subscribe to Entrepreneur for $5
Subscribe

TransUnion's (TRU) Q3 Earnings Surpass Estimates, Up Y/Y

TransUnion's (TRU) third-quarter 2021 revenues increase year over year.

By
This story originally appeared on Zacks

TransUnion TRU reported impressive third-quarter 2021 results, wherein its earnings and revenues surpassed the Zacks Consensus Estimate.

- Zacks

Adjusted earnings of $1.01 per share beat the consensus mark by 8.6% and increased 24.7% year over year. Total revenues of $792 million beat the consensus mark by 2.2% and increased 14% year over year on a reported basis, 13% on a constant-currency basis and 12% on an organic constant-currency basis.

TransUnion’s shares have gained 28.3% over the past year, outperforming the 18.3% growth of the industry it belongs to.

TransUnion Price, Consensus and EPS Surprise TransUnion Price, Consensus and EPS Surprise

TransUnion price-consensus-eps-surprise-chart | TransUnion Quote

Revenues by Segments

U.S. Market revenues of $498 million were up 14% year over year on a reported basis and 12% on an organic basis. Within the segment, Financial Services revenues of $278 million climbed 11% year over year. Emerging Vertical revenues, including Healthcare, Insurance and all other verticals, were $221 million, up 17% on a reported basis and 14% on an organic basis.

International revenues increased 23% year over year on a reported basis, and 18% on a constant-currency basis, to $178 million. Revenues from Canada increased 10% on a reported basis, and 4% on a constant-currency basis, to $31 million. Revenues from the United Kingdom came in at $55 million, up 24% on a reported basis and 16% on a constant-currency basis. India revenues increased 44% on a reported as well as on a constant-currency basis, to $35 million. Asia-Pacific revenues came in at $16 million, up 10% on a reported basis and 11% on a constant-currency basis.

Revenues from Latin America increased 23% on a reported basis and 22% on a constant-currency basis, to $27 million. Africa revenues were up 23% on a reported basis and 8% on a constant-currency basis, to 15 million.

Consumer Interactive segment revenues improved 3% from the prior-year quarter figure to $135 million.

Operating Performance

Adjusted EBITDA was $327 million, up 21% year over year on a reported basis, 20% on a constant-currency as well as organic constant-currency basis. Adjusted EBITDA margin came in at 41.3%, up 250 basis points year over year.

Key Balance Sheet and Cash Flow Figures

TransUnion had $709 million in cash and cash equivalents at the end of the quarter compared with $526 million at the end of the prior quarter. Long-term debt was $3.3 billion, flat with the prior-quarter figure. The company generated $280 million in cash from operating activities and CapEx was $61 million. It paid out $18.2 million in dividends in the quarter.

Outlook

For the fourth quarter of 2021, revenues are anticipated between $764 million and $774 million, the midpoint ($769 million) of which is higher than the current Zacks Consensus Estimate of $764.62 million.

Adjusted earnings are anticipated to be between 88 and 91 cents per share. The Zacks Consensus Estimate for the same was 88 cents. Adjusted EBITDA is anticipated between $293 million and $301 million.

For 2021, the company expects revenues between $3.075 billion and $3.085 billion, higher than the Zacks Consensus Estimate of $3.06 billion.

Adjusted earnings are anticipated between $3.76 and $3.79 per share, above the Zacks Consensus Estimate of $3.69. Adjusted EBITDA is anticipated between $1.239 billion and $1.247 billion.

Currently, TransUnion carries a Zacks Rank #3 (Hold).

You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.

Recent Performance of Some Other Business Services Companies

Equifax EFX reported better-than-expected third-quarter 2021 results. Adjusted earnings of $1.85 per share beat the Zacks Consensus Estimate by 7.6% but declined 1.1% on a year-over-year basis. Revenues of $1.22 billion outpaced the consensus estimate by 3.6% and improved 14.5% year over year.

IQVIA Holdings IQV reported impressive third-quarter 2021 results, with earnings per share of $2.17 beating the consensus mark by 1.9% and improving 33.1% on a year-over-year basis. Total revenues of $3.39 billion outpaced the consensus estimate by 1% and increased 21.7% year over year.

Omnicom OMC reported third-quarter 2021 adjusted earnings of $1.65 per share that beat the consensus mark by 20.4% and increased 36.4% year over year. Total revenues of $3.4 billion surpassed the consensus estimate by 0.6% and increased 7.1% year over year.



Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

 

Omnicom Group Inc. (OMC): Free Stock Analysis Report

 

Equifax, Inc. (EFX): Free Stock Analysis Report

 

TransUnion (TRU): Free Stock Analysis Report

 

IQVIA Holdings Inc. (IQV): Free Stock Analysis Report

 

To read this article on Zacks.com click here.

 

Zacks Investment Research